三种新生血管其他类型决定增殖性糖尿病视网膜病变的差异临床特征
该研究基于荧光素血管造影及血管与结构OCT,将增殖性糖尿病视网膜病变中的新生血管其他(NVE)按起源和形态分为三型,比较其地形分布、玻璃体视网膜界面及全视网膜光凝反应。
要点
- NVE可按起源和形态分为三型,各型地形分布不同。
- Type 1多位于血管弓附近,Type 2分布更周边。
- 全视网膜光凝后3个月,Type 2消退率最佳(P<0.01)。
核心结论
- 三种NVE类型决定了不同的地形分布、玻璃体视网膜界面特征及对全视网膜光凝的差异反应。
研究设计与样本
- 基于荧光素血管造影及血管与结构OCT对NVE进行分型,比较三型的分布、界面和光凝反应。
主要发现
- Type 1 NVE集中于血管弓沿或邻近区域,Type 2分布较Type 1和Type 3更周边。
- 弓桥样玻璃体视网膜界面占Type 1 NVE的79%。
- 平坦及平坦前移玻璃体视网膜界面分别占Type 2的95%和Type 3的100%。
- 全视网膜光凝后3个月,Type 1、2、3 NVE消退率分别为82%、100%、80%。
- Type 2 NVE光凝后消退率最佳(均P<0.01)。
关键数值与推荐
- Type 1 NVE:弓桥样玻璃体视网膜界面占79%。
- Type 2 NVE:平坦及平坦前移界面占95%。
- Type 3 NVE:平坦及平坦前移界面占100%。
- 光凝后3个月消退率:Type 1为82%,Type 2为100%,Type 3为80%。
- Type 2消退率优于其他两型(均P<0.01)。
临床怎么用
- 可根据NVE分型评估增殖性糖尿病视网膜病变的治疗反应和预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To explore the pathological features and clinical significance of three types of neovascularization elsewhere (NVE) in proliferative diabetic retinopathy. METHODS: Neovascularization elsewhere was classified based on the origins and morphologic features using fluorescein angiography and angiographic and structural optical coherence tomography. The topographical distribution, vitreoretinal interface, and responsiveness to panretinal photocoagulation were compared among three types of NVE. RESULTS: One hundred and twenty-seven NVEs were classified into three types. Type 1 NVE was concentrated along or adjacent to vascular arcades; Type 2 was distributed more peripherally than were Types 1 and 3 NVE. The arch bridge-like vitreoretinal interface accounted for 79% of Type 1 NVE. The flat and flat-forward vitreoretinal interface accounted for 95% and 100% in Type 2 and Type 3 NVE, respectively. At 3 months after panretinal photocoagulation, the regression rates for Types 1, 2, and 3 NVE were 82%, 100%, and 80%, respectively. Type 2 NVE showed best regression rate after panretinal photocoagulation (both P < 0.01). CONCLUSION: Three types of NVE determine the distinctly topographical distributions, vitreoretinal interface features, and differential responsiveness to panretinal photocoagulation treatment. This new concept may have important clinical implications in assessing the treatment and prognosis of proliferative diabetic retinopathy.
引用
- Pan J, Chen F, Chen D, et al. NOVEL THREE TYPES OF NEOVASCULARIZATION ELSEWHERE DETERMINE THE DIFFERENTIAL CLINICAL FEATURES OF PROLIFERATIVE DIABETIC RETINOPATHY. Retina. 2021. PMID: 33136976. doi:10.1097/IAE.0000000000003005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。